Philips DIGITAL

Target: Koninklijke Philips N.V. (Royal Philips) Research date: 25 October 2026 Domain: Digital

Enterprise Technology Stack & Vendor Relationships

Israeli-origin software and technology relationships

On 8 April 2021, Philips announced a strategic collaboration with Tel Aviv-based Ibex Medical Analytics to jointly commercialise AI-powered digital pathology technology, integrating Philips’ digital pathology systems with Ibex’s Galen AI platform for cancer detection and clinical diagnosis.¹

On 24 March 2025, Philips announced an expansion of the Ibex partnership, including improved integration between the Philips IntelliSite Pathology Solution and Ibex AI applications for prostate, breast and gastric cancer diagnostics. Philips stated that digital slides could be transferred automatically to Ibex applications for analysis. The collaboration was therefore documented as ongoing after November 2024.²

In its 2023 digital pathology reporting, Philips stated that 35 pathology laboratories were using its solution in combination with Ibex’s Galen AI diagnostics platform. The reported figure relates to 2023 and is not independently confirmed as the deployment count in October 2026.³

Philips’ digital pathology product documentation describes an open platform that supports third-party AI applications, identifies Ibex as an integration partner and describes interoperability using iSyntax files and software development interfaces.⁴

On 2 March 2021, Philips announced a partnership with Israeli company DiA Imaging Analysis to integrate automated ultrasound image-quantification software into point-of-care diagnostic workflows.⁵

Enterprise cybersecurity and software vendors

Philips’ October 2026 security advisory identifies Ivanti Connect Secure vulnerabilities and refers to Philips Vue PACS 12.2 and managed infrastructure patching; the same advisory archive documents Philips’ assessment of vulnerabilities involving Citrix NetScaler and JFrog Artifactory. These records establish product-security investigation and mitigation activity but do not, by themselves, establish direct enterprise procurement of those vendors’ products.⁶

For verified direct or indirect enterprise subscriptions to Check Point, Wiz, SentinelOne, CyberArk, NICE, Verint, Claroty or Palo Alto Networks: no public evidence identified.

Scale of technology dependency

Philips’ March 2025 Ibex announcement describes the integration of AI cancer-diagnostic applications directly into digital pathology workflows, including case prioritisation, image analysis and reporting support.²

Philips’ 2024 digital pathology release describes the IntelliSite platform as enabling integration of third-party AI diagnostic applications through cloud-based services and an open software architecture.⁷

Procurement and systems integration

On 26 November 2024, Philips announced an expanded strategic collaboration with Amazon Web Services covering its healthcare informatics portfolio, including radiology, digital pathology, cardiology, AI visualisation and cloud-enabled clinical workflows. Philips reported that more than 150 North and Latin American healthcare sites had already transitioned to HealthSuite Imaging on AWS.⁸

In October 2025, Philips documented patient-monitoring interoperability partnerships with Dräger, Hamilton Medical, Getinge, Löwenstein and B. Braun. The announced work concerned interoperability among clinical monitoring, ventilation, anaesthesia and infusion systems.⁹

For evidence that a major Philips systems integrator specifically mandated or deployed Israeli-origin cybersecurity or surveillance technology: no public evidence identified.

March 2025–October 2026 - no public evidence identified: the reviewed Philips partnership announcements, Ibex sub-processor register, February 2026 Data Protection Addendum and Ibex privacy documentation do not disclose a Philips/Ibex-specific infrastructure-control agreement, named AWS hosting region, operational-access matrix, source-code ownership allocation or contractual assignment of the integrated pathology workflow’s R&D pipeline to an Israeli entity. Ibex’s published July 2026 website privacy policy expressly excludes personal data processed through commercial customer products from its scope; consequently, its statements about processing in Israel and other countries cannot establish where Philips/Ibex pathology slides are processed. The available evidence supports Ibex’s contractual processing responsibilities and its use of AWS, while leaving exclusive infrastructure control, access arrangements and deployment-specific research-data flows unresolved.^{10, 11, 12, 13}

Surveillance, Biometrics & Retail Technology

Facial recognition and biometric identification

No public evidence identified of Philips deploying Israeli-origin facial recognition, gait recognition, identity-matching or retail surveillance systems supplied by Trigo, BriefCam, AnyVision/Oosto or Trax.

Clinical image processing and medical monitoring

Philips’ 2018 EPD Solutions acquisition announcement describes a system generating three-dimensional cardiac anatomy images and identifying catheter position during electrophysiology procedures. The disclosed application is clinical cardiac imaging and treatment guidance.¹⁴

Philips’ current Israeli R&D description identifies KODEX-EPD technology as an electro-anatomical imaging and navigation system for catheter-based treatment of cardiac arrhythmias.¹⁵

Philips’ hospital patient-monitoring technology documentation describes systems combining bedside monitors, central monitoring, mobile clinical applications and remote patient-monitoring devices to provide streaming clinical information.¹⁶

Predictive analytics and workforce surveillance

No public evidence identified of Philips deploying Israeli-origin predictive policing, workforce surveillance, social-media monitoring or law-enforcement behavioural profiling systems.

Third-party surveillance deployments

No public evidence identified that Israeli-origin retail surveillance, predictive policing or military intelligence technology reaches Philips through a documented bundled enterprise platform or managed security provider.

Cloud Infrastructure, Data Residency & Sovereign Cloud Participation

Healthcare cloud infrastructure

On 26 November 2024, Philips announced that its cloud-enabled diagnostic portfolio would use AWS services for managing and analysing medical imaging, pathology and other clinical records. The announcement also described development of generative AI applications using Amazon Bedrock.⁸

Philips’ November 2024 RSNA announcement further described cloud-based informatics, remote imaging workflows, AI-enabled visualisation and clinical data-management functions.¹⁷

Philips’ HealthSuite documentation marketed in Israel describes interoperable cloud solutions for radiology, cardiology, digital pathology, acute care and patient monitoring, including the integration of data from multiple clinical environments.¹⁸

Israeli data centres

No public evidence identified that Philips directly owns, leases or operates a named data centre in Israel.

No public evidence identified establishing an Israeli cloud-hosting region for identifiable patient information processed by every Philips/Ibex deployment.

Data-exposure and processing jurisdiction

Philips’ March 2025 description of its Ibex integration establishes a workflow in which digitised pathology slides may be transferred automatically to Ibex AI applications for analysis. The announcement does not identify the hosting jurisdiction of each installation or establish that identifiable patient data is necessarily transferred to Israel.²

Philips’ Israeli R&D documentation identifies cloud-enabled enterprise imaging development at Algotec in Ra’anana and oncology informatics development involving cloud computing, analytics and machine learning in Haifa and Petach Tikva. The material establishes an Israeli engineering footprint but does not specify where each customer’s clinical data is stored or processed.¹⁵

Project Nimbus and sovereign cloud

No public evidence identified of Philips participating as a contractor, subcontractor or named technology supplier in Project Nimbus.

No public evidence identified of Philips providing a dedicated sovereign cloud, data-sovereignty platform or government cloud-resilience service to Israeli defence or intelligence institutions.

Ibex Medical Analytics’ publicly available sub-processor register, published in August 2025, identifies Amazon Web Services (AWS) as its cloud-computing infrastructure provider for processing customer data. The register explicitly specifies that the processing country is determined “in accordance with customer choice.” This is direct technical and contractual evidence that Ibex uses AWS infrastructure and supports customer-selected processing jurisdictions. It does not establish that pathology slides are necessarily hosted in Israel or that an Israeli entity owns or operates the underlying AWS infrastructure. The register does not identify the AWS regions selected by individual Philips/Ibex customers.¹⁰

Ibex’s February 2026 Data Protection Addendum identifies Ibex Medical Analytics Ltd., together with its subsidiaries and affiliates, as the contracting service provider and assigns Ibex the role of data processor, with customers acting as data controllers. The agreement expressly includes patient-related customer data within its scope and authorizes Ibex to process pseudonymized medical information for service delivery, maintenance, support, enhancement, deployment, improvement and optimization. It also authorizes Ibex to engage sub-processors, including AWS, subject to contractual safeguards. These provisions establish a contractual role for the Israeli Ibex entity in processing customer medical data and managing service-related processing activities, although the agreement does not establish that Ibex’s Israeli personnel routinely access every customer’s slides or that clinical data is processed in Israel.¹¹

Ibex’s February 2026 Data Protection Addendum provides additional contractual limitations relevant to infrastructure control. Section 2 requires Ibex to process personal data according to customer instructions, except where applicable law requires otherwise. Section 9 provides for deletion from Ibex and sub-processor systems following termination or customer request and permits deletion after 21 days unless a different retention period is agreed. Section 10 expressly contemplates cross-border transfers, subject to applicable legal safeguards. Section 11 states that identification data is not managed within Ibex’s cloud and that service data is encrypted in transit and at rest. These provisions establish contractual processing responsibilities and safeguards; they neither prove exclusive Israeli operational control nor independently verify compliance in individual deployments.¹¹

Philips’ 11 March 2026 announcement separately identifies AWS as the infrastructure provider for its cloud-enabled IntelliSite Pathology Solution on HealthSuite. Philips describes this offering as supporting image storage, management and analysis, while specifying that AI interoperability will initially involve Ibex AI. The announcement qualifies the cloud-enabled product and its AI interoperability as works in progress without guaranteed future availability. This establishes a publicly described Philips/AWS infrastructure architecture with Ibex as an AI integration partner, but does not demonstrate that the announced cloud architecture had entered production or identify the operator of Ibex’s application infrastructure in any specific customer installation.¹²

Defence, Intelligence & Security Sector Technology Relationships

Israeli state procurement

An Israeli government procurement notice published on 17 November 2024 identifies a proposed single-supplier service arrangement for a Philips CT Big Bore system at Tel Aviv Sourasky Medical Center. The published financial scope was USD 246,000 for a 36-month arrangement, with dates from 4 November 2024 to 4 November 2027 and Philips Electronics (Israel) Ltd. named as supplier.¹⁹

An Israeli government procurement notice published on 25 February 2024 identifies maintenance services for Philips ultrasound systems at Rambam Medical Center, naming Medtechnica Ltd. as supplier and specifying NIS 3.2 million over the stated March 2024–March 2026 contract period.²⁰

Both cited procurement notices relate to civilian healthcare institutions and medical equipment or associated maintenance.^{19, 20}

Military and intelligence contracts

No public evidence identified of a direct Philips technology contract with the Israeli Ministry of Defence, Israel Defence Forces, Mossad, Shin Bet or Israeli military intelligence.

No public evidence identified that the specific Philips hospital contracts described above were military or intelligence procurements.

Dual-use technology

Philips’ 2018 EPD Solutions announcement establishes the commercial availability of high-resolution anatomical imaging and catheter navigation technology for clinical electrophysiology procedures.¹⁴

No public evidence identified that Philips’ EPD cardiac navigation technology was deployed for military surveillance, battlefield intelligence or weapons guidance.

Offensive cyber and digital weapons

No public evidence identified of Philips developing, licensing, selling or maintaining offensive cyber capabilities, zero-day exploitation platforms or digital weapons for Israeli state agencies.

AI, Algorithmic & Autonomous Systems

Clinical diagnostic artificial intelligence

In April 2021, Philips and Ibex Medical Analytics announced the commercial integration of AI-powered cancer diagnostics with Philips digital pathology technology. Their stated applications included improving diagnostic accuracy, reporting efficiency and clinical workflows.¹

The March 2025 partnership expansion described the use of Ibex AI for prostate, breast and gastric cancer diagnostics, including automated processing of digital pathology slides through integrated clinical workflows.²

In March 2021, Philips and DiA Imaging Analysis announced cooperation on ultrasound AI image quantification, including automated clinical measurements in point-of-care environments.⁵

In May 2023, Globes reported that Philips was acquiring DiA Imaging Analysis, citing the company’s AI-powered ultrasound analysis and automated examination guidance technology.²¹

AI development in Israel

The Israel Innovation Authority’s public record for Philips Medical Systems Technologies identifies activities including medical image processing, detection, clinical software, CT, ultrasound and photon-counting CT. The authority also records company entries in pre-product research programmes in 2023 and 2025.²²

Philips’ Israeli R&D website identifies oncology informatics research using machine learning, natural-language processing, analytics and cloud technologies in Haifa and Petach Tikva.¹⁵

AI provision to Israeli state institutions

Philips’ 2026 announcement concerning the COMBINE-CT research project identifies Philips and Israel’s Sheba Medical Center among 11 partners in a four-year medical imaging research consortium with a total budget of EUR 10 million. The announcement identifies a shared research programme; it does not establish a separate bilateral AI procurement contract between Philips and Sheba.²³

For verified provision of AI decision-support technology to Israeli military or intelligence bodies: no public evidence identified.

Training data and civilian population data

No public evidence identified that Philips trained military, policing or intelligence AI models on intercepted communications or surveillance-derived datasets originating from Israel or occupied Palestinian territories.

No public evidence identified establishing that patient-identifiable records processed through Philips/Ibex systems are routinely transferred into Israeli-hosted model-training repositories.

Autonomous targeting and lethal systems

No public evidence identified of Philips providing autonomous target-generation, fire-control or lethal decision-support systems to Israeli military or security forces.

No public evidence identified of Philips supplying purpose-built kinetic targeting software falling within the separate Military domain.

Technology Ecosystem & R&D Footprint

Israeli research and engineering operations

Philips’ Israeli R&D recruitment website identifies multiple research locations and functions: CT and PET-CT development in Haifa; imaging applications and oncology informatics in Haifa and Petach Tikva; EPD cardiac mapping technology in Caesarea; Volcano software R&D in Netanya; and Algotec/Carestream enterprise imaging development in Ra’anana.¹⁵

The Israel Innovation Authority identifies Philips Medical Systems Technologies Ltd. under registration number 512695560, lists approximately 1,300 employees, and identifies medical imaging and diagnostic engineering as its principal technology activities. The date to which the published employee figure relates was not established.²²

Acquisition of EPD Solutions

[pre-2020] On 5 June 2018, Philips announced an agreement to acquire Israeli company EPD Solutions to extend its Image-Guided Therapy portfolio into cardiac mapping and catheter navigation. Philips’ subsequent Israeli R&D documentation identifies EPD technology and engineering operations within the group, establishing later operational continuity.^{14, 15}

Acquisition of Algotec-related operations

[pre-2020] Philips’ Israeli R&D website states that its August 2019 acquisition of Carestream Healthcare Information Systems included Algotec, an Israeli research centre developing cloud-enabled enterprise imaging technology. The same Philips recruitment source continues to identify Algotec/Carestream research operations in Ra’anana.¹⁵

DiA Imaging Analysis acquisition

On 7 May 2023, Globes reported that Philips had acquired Israeli AI ultrasound company DiA Imaging Analysis, following its earlier investment and commercial cooperation with the business.²¹

On 17 May 2023, Israeli law firm Herzog confirmed that it represented Philips in the DiA acquisition and stated that Philips had previously invested in the company.²⁴

Israeli public research funding

The Israel Innovation Authority records Philips Medical Systems Technologies under pre-product research programme entries for 2023 and 2025. The consulted public record does not specify a verified monetary grant amount for those entries.²²

Collaborative research with Israeli institutions

Philips’ 2026 COMBINE-CT announcement names Sheba Medical Center among the project’s research partners. The collaboration covers development and clinical validation of cardiovascular CT technologies through a European public-private research programme.²³

Patents and intellectual property

Philips’ Israeli R&D documentation identifies specialised engineering activity in medical imaging, clinical software, cardiac mapping and cloud-enabled enterprise imaging.¹⁵

For a specifically documented Philips patent assignment, jointly owned patent, exclusive intellectual-property licence or named patent-licensing agreement with Technion, Hebrew University or the Weizmann Institute: no public evidence identified.

Controlling principals and investments

No public evidence identified establishing a relevant personal investment by a Philips controlling principal in an Israeli military surveillance, SIGINT or offensive cybersecurity firm.

A complete independent review of all current directors’ and major shareholders’ private investment holdings was not established.

Ibex’s February 2026 Data Protection Addendum expressly includes service enhancement, improvement and optimization among the permitted purposes of processing customer data, subject to the principal agreement and applicable anonymization provisions. This establishes a contractual mechanism under which Ibex may perform product-improvement activities involving customer data within the agreed processing framework. It does not establish that identifiable pathology slides are transferred to Israeli research facilities, that Israeli employees have unrestricted access to customer datasets, or that individual Philips/Ibex customers have authorized the use of their clinical data for model training.¹¹

Civil Society Scrutiny & Regulatory History

NGO and United Nations investigations

No public evidence identified in the reviewed material of a specialist NGO investigation specifically documenting Philips software, cloud infrastructure or clinical AI technology being used in an Israeli settlement surveillance programme.

No independently verified Philips-specific finding was established from the UN settlement-business database or A/HRC/59/23 during this research.

Boycott and divestment campaigns

No public evidence identified of a documented organised boycott or divestment campaign specifically directed at Philips for supplying digital surveillance, AI targeting or cloud services to Israeli military or intelligence bodies.

Regulatory and legal proceedings

No public evidence identified of an export-control prosecution, sanctions action or regulatory proceeding specifically involving Philips’ digital technology provision to Israeli defence or intelligence institutions.

Documented cybersecurity regulatory context

In its October 2026 security advisory archive, Philips described product-security assessments concerning third-party software vulnerabilities, including an Ivanti Connect Secure advisory dated 15 October 2026. This documentation concerns cybersecurity risk management and does not identify an Israeli military or intelligence procurement arrangement.⁶

Technology activity after July and November 2024

Philips documented continuing Israeli-origin AI integration through its expanded Ibex partnership announcement of 24 March 2025, following both 19 July 2024 and November 2024.²

The Israel Innovation Authority’s corporate record lists a 2025 research-programme entry for Philips Medical Systems Technologies in Israel.²²

Philips’ 2026 COMBINE-CT announcement separately documents research collaboration involving Israeli medical institution Sheba Medical Center.²³

No public evidence identified establishing that the cited activities involved settlement infrastructure, military surveillance, offensive cyber operations or purpose-built military targeting systems.